Sunrest Lifescience Limited — Important, 29-03-2025: Disclosure of material issue

Hetvi Lifesciences Limited has allotted 21,23,000 equity shares to Sunrest Lifesciences Limited, converting a loan into equity at a price of ₹26 per share, totaling ₹5.52 Cr. This allotment raises Hetvi's paid-up share capital to ₹4.12 Cr across 41,23,000 shares. Following this transaction, Sunrest will now hold 51.49% of Hetvi's share capital, making it a subsidiary. This development may enhance Sunrest's control and operational synergies within the healthcare sector, offering a positive outlook for investor sentiment.